| 12/09/22 | 07:00:08 | 12 Sept 2022 | | Sareum notes FDA approval of first TYK2 Inhibitor |
| 28/07/22 | 07:00:08 | 28 Jul 2022 | | CTA application to MHRA and Corporate Update |
| 04/07/22 | 07:00:06 | 4 Jul 2022 | | Sareum notes GSK's completed acquisition of Sierra |
| 26/04/22 | 07:00:08 | 26 Apr 2022 | | Sareum to Present at BioTrinity 2022 Conference |
| 13/04/22 | 16:00:17 | 13 Apr 2022 | | Sareum notes acquisition of Sierra Oncology by GSK |
| 13/04/22 | 11:05:47 | 13 Apr 2022 | | Second Price Monitoring Extn |
| 13/04/22 | 11:00:25 | 13 Apr 2022 | | Price Monitoring Extension |
| 11/04/22 | 07:00:08 | 11 Apr 2022 | | European Patent Granted for Sareum’s SDC-1802 |
| 08/04/22 | 16:41:24 | 8 Apr 2022 | | Second Price Monitoring Extn |
| 08/04/22 | 16:36:05 | 8 Apr 2022 | | Price Monitoring Extension |
| 06/04/22 | 14:06:27 | 6 Apr 2022 | | Second Price Monitoring Extn |
| 06/04/22 | 14:00:46 | 6 Apr 2022 | | Price Monitoring Extension |
| 16/03/22 | 07:00:02 | 16 Mar 2022 | | SDC-1801: Preclinical Toxicology Report Received |
| 09/03/22 | 11:06:04 | 9 Mar 2022 | | Second Price Monitoring Extn |
| 09/03/22 | 11:00:34 | 9 Mar 2022 | | Price Monitoring Extension |
| 28/02/22 | 15:50:02 | 28 Feb 2022 | | Results of EGM |
| 21/02/22 | 07:00:07 | 21 Feb 2022 | | Half-year Report |
| 14/02/22 | 14:06:15 | 14 Feb 2022 | | Second Price Monitoring Extn |
| 14/02/22 | 14:01:10 | 14 Feb 2022 | | Price Monitoring Extension |
| 04/02/22 | 07:00:04 | 4 Feb 2022 | | Publication of Circular; Notice of General Meeting |
| 28/01/22 | 08:11:38 | 28 Jan 2022 | | Correction - Issue of Warrants |
| 28/01/22 | 07:00:07 | 28 Jan 2022 | | Issue of Warrants |
| 25/01/22 | 07:00:07 | 25 Jan 2022 | | Sareum to Participate in Edison Open House Event |
| 17/12/21 | 07:00:07 | 17 Dec 2021 | | Subscription to raise £1.63m to progress SDC-1801 |
| 16/12/21 | 16:21:58 | 16 Dec 2021 | | Result of AGM |
| 16/12/21 | 07:00:06 | 16 Dec 2021 | | AGM Statement |
| 15/12/21 | 07:00:04 | 15 Dec 2021 | | Intention to grant notice - EU patent for SDC-1802 |
| 07/12/21 | 07:00:03 | 7 Dec 2021 | | AGM Update |
| 23/11/21 | 12:57:22 | 23 Nov 2021 | | Director/PDMR Shareholding |
| 19/11/21 | 07:00:04 | 19 Nov 2021 | | Notice of AGM |
| 03/11/21 | 15:00:02 | 3 Nov 2021 | | Exercise of Share Options and Director Dealings |
| 29/10/21 | 07:00:07 | 29 Oct 2021 | | Appointment of Joint Corporate Broker |
| 25/10/21 | 07:00:13 | 25 Oct 2021 | | Sareum: Final Results for Year Ended 30 June 2021 |
| 21/10/21 | 08:32:41 | 21 Oct 2021 | | Correction - Notice of Results |
| 21/10/21 | 07:00:05 | 21 Oct 2021 | | Notice of Results and Investor Presentation |
| 07/10/21 | 10:42:53 | 7 Oct 2021 | | US Patent Granted for SDC-1802 TYK2/JAK1 Inhibitor |
| 29/09/21 | 10:46:46 | 29 Sept 2021 | | Reference to SRA737 Timeline at Cantor Conference |
| 19/08/21 | 07:00:06 | 19 Aug 2021 | | Trading Statement |